MedCap president pleads guilty to huge private-placement fraud

MAY 13, 2012
It looks like jail time for a former principal of Medical Capital Holdings Inc., the firm behind the fraudulent private placements that destroyed dozens of broker-dealers and wiped out almost $1 billion in investor cash. Former Medical Capital president Joseph J. Lampariello last Monday pleaded guilty to wire fraud and faces up to 21 years in federal prison and an order to pay $49 million in restitution, according to a report in The Orange County Register. The press report stated that the plea agreement was filed under seal in U.S. District Court in the Central District of California. Calls placed last Tuesday to Mr. Lampariello's attorney, Amy Karlin, to confirm the report weren't returned. Assistant U.S. Attorney Jennifer Waier didn't return calls. Thomas Mrozek, a spokesman for the U.S. Attorney's Office in Los Angeles, declined to comment. Between 2003 and 2009, Medical Capital raised almost $2 billion by selling private notes, purportedly to buy discounted medical receivables such as unpaid doctor or hospital bills that the firm would collect at full price. A court-appointed receiver later charged that Medical Capital was a “Ponzi-like scheme” that resulted in about $1 billion in losses for 12,000 investors.

WIPED OUT

Dozens of independent broker-dealers sold MedCap notes. Many have since gone out of business due to massive costs from lawsuits by investors looking to regain money lost in the fraud. Medical Capital's former chief executive, Sidney Field, hasn't been criminally charged. Both Mr. Field and Mr. Lampariello, 58, were sued by the Securities and Exchange Commission in July 2009 for fraud in their running of Medical Capital's last offering, Medical Provider Funding Corp. VI, known as MedCap VI in the brokerage industry. That case was later closed in order for criminal proceedings to continue. According to the Justice Department's information filing against Mr. Lampariello last month, he defrauded the note holders of MedCap VI from August 2008 until June 2009. Investors were told that the proceeds raised by MedCap VI would be used to purchase account receivables, make loans, pay sales commissions and other costs, and provide funds for general operating purposes, according to the filing. In fact, Mr. Lampariello and others “misappropriated investor funds” in order to “make Ponzi-type payments to note holders from earlier” partnerships and to pay fees to Medical Capital. He caused MedCap VI note holders to lose about $39 million, according to the filing. Mr. Lampariello, according to a separate federal charge, “earned $6.2 million from MedCap from 2004 through 2008, including $1.47 million in 2008 alone, but failed to file federal tax returns. On Monday, he pleaded guilty to a single count of failing to file a tax return in 2008,” The Orange County Register reported. When the SEC took over, the company reportedly owned a medical nuclear reactor and two closed hospitals that had lost their operating licenses. MedCap also was reportedly involved in producing a feature-length movie about a Mexican Little League team. [email protected]

Latest News

Advisor moves: Atlas tops $1B as Wells Fargo, UBS add bank veterans
Advisor moves: Atlas tops $1B as Wells Fargo, UBS add bank veterans

Wells Fargo adds two bank-channel recruits, UBS lands a JPMorgan Chase veteran, and a multi-family office lifts Atlas past $1B

Advisor mom’s son used her password to log into clients’ accounts, sell deal with conflicts, according to Washington state
Advisor mom’s son used her password to log into clients’ accounts, sell deal with conflicts, according to Washington state

“The state comes down on you in years when you make 40% returns for clients,” said Bill Swayne, the advisor and son of Candace Swayne.

Osaic in talks with Anthropic as AI reshapes advisor workforce
Osaic in talks with Anthropic as AI reshapes advisor workforce

The Independent broker-dealer giant has had “active conversations” with the Claude maker, which is days away from its expected IPO

The retirement milestone advisors aren't tracking
The retirement milestone advisors aren't tracking

For Gen X clients entering life after work, answering the financial question isn't enough to solve the entire retirement equation.

Wealthtech firms target stock pay, pensions and heirs for advisors
Wealthtech firms target stock pay, pensions and heirs for advisors

Tools from Grantd, Income Lab and Healthspan Wealth aim to keep RIAs involved in clients’ biggest money decisions

SPONSORED Best Practices for Engaging Women Around Alternatives

Growing wealth, evolving priorities, and untapped opportunities are reshaping how women approach long-term investing.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.